- Home
- J&J Innovative Medicine
J&J Innovative Medicine
“I had four strokes and two brain surgeries—and survived”
Lisa Deck was just 21 when she had her first stroke. She would go on to have three more, as well as face a rare diagnosis of moyamoya disease. For World Stroke Day, we’re sharing her incredible story of survival and living with a chronic illness.
How Johnson & Johnson is helping tackle a devastating tropical disease that impacts kids
A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.
5 things to know about the 2018 Janssen U.S. Transparency Report
The company just released its third annual report and leaders from across Janssen share some top takeaways, including a new initiative to include the list price and potential out-of-pocket costs for its most frequently prescribed medicine.
He beat childhood cancer. Now he’s trying to save lives as a cancer researcher
Brad Heidrich’s diagnosis with a deadly cancer at age 13 changed the course of his life—and inspired the person he would become: a Janssen scientist dedicated to working on therapies for blood cancer. For National Cancer Survivor Month, we share his incredible story.
Lung cancer: What you need to know about your risk factor—even if you’ve never smoked
Some 20% of people diagnosed with the disease haven’t touched a cigarette. For Healthy Lung Month, scientists who’ve dedicated their research to defeating lung cancer discuss why early detection is so key—and what you can do to protect yourself.
Johnson & Johnson named a 2019 Fortune World’s Most Admired Company
The company has been honored with a spot on the prestigious list for the 17th year in a row for its innovative spirit and commitment to social responsibility, among other respected attributes.
What you need to know about Johnson & Johnson’s 2018 full-year earnings report
Check out this infographic breakdown of the company’s annual earnings report, with key performance highlights from its consumer, pharmaceutical and medical devices businesses over the last year.
133 years of innovative Credo-driven decisions that have made Johnson & Johnson the healthcare leader it is today
To help mark 75 years since the company went public, we’re retracing some of the pivotal acquisitions, inventions and decisions that have guided the company for more than a century.
New Year, new vision: Meet a woman determined to find a cure for Type 2 diabetes
Hundreds of millions of people worldwide have type 2 diabetes. And Chiara Magnone has her sights set on changing what it means to live with the condition, as well as how common complications like chronic kidney disease are treated.
New Year, new vision: Meet a scientist who spends his days studying the microscopic world of the microbiome
Trillions of beneficial bacteria live in and all around us. What if we could use them to our advantage, to do everything from prevent diabetes to reduce inflammation? Dirk Gevers, Ph.D., Global Head of the Janssen Human Microbiome Institute, shares how his team is already well on that research path.